I‐Jun Lau

837 total citations
7 papers, 354 citations indexed

About

I‐Jun Lau is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, I‐Jun Lau has authored 7 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in I‐Jun Lau's work include Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and Epigenetics and DNA Methylation (2 papers). I‐Jun Lau is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and Epigenetics and DNA Methylation (2 papers). I‐Jun Lau collaborates with scholars based in United Kingdom, United States and Switzerland. I‐Jun Lau's co-authors include Thomas A. Milne, Claudio D. Stern, Lawrence Bodenstein, Octavian Voiculescu, Hélène Royo, Mathijs A. Sanders, Vaia Stavropoulou, Sabine Juge, Peter J.M. Valk and Michael Kyba and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

I‐Jun Lau

7 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I‐Jun Lau United Kingdom	6	276	132	79	36	32	7	354
Sabine Juge Switzerland	7	253 0.9×	155 1.2×	49 0.6×	39 1.1×	17 0.5×	10	314
Susan A. Heilman United States	6	203 0.7×	138 1.0×	94 1.2×	30 0.8×	15 0.5×	6	304
Alix Rousseau France	5	199 0.7×	75 0.6×	54 0.7×	30 0.8×	19 0.6×	6	281
Xinghui Zhao China	8	194 0.7×	81 0.6×	35 0.4×	33 0.9×	25 0.8×	16	245
Meike Fischer Germany	9	167 0.6×	137 1.0×	55 0.7×	27 0.8×	18 0.6×	11	307
Bert van der Reijden Netherlands	7	201 0.7×	182 1.4×	71 0.9×	33 0.9×	8 0.3×	13	314
Akshay K. Ahuja Switzerland	5	267 1.0×	91 0.7×	85 1.1×	26 0.7×	40 1.3×	6	432
Craig D. Jude United States	7	275 1.0×	186 1.4×	28 0.4×	23 0.6×	32 1.0×	10	394
Eva Hilgenfeld Germany	10	194 0.7×	111 0.8×	66 0.8×	44 1.2×	18 0.6×	13	318
Pekka Jaako Sweden	9	307 1.1×	98 0.7×	51 0.6×	16 0.4×	20 0.6×	16	389

Countries citing papers authored by I‐Jun Lau

Since Specialization

Citations

This map shows the geographic impact of I‐Jun Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Jun Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Jun Lau more than expected).

Fields of papers citing papers by I‐Jun Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Jun Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Jun Lau. The network helps show where I‐Jun Lau may publish in the future.

Co-authorship network of co-authors of I‐Jun Lau

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Jun Lau. A scholar is included among the top collaborators of I‐Jun Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Jun Lau. I‐Jun Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Godfrey, Laura, Nicholas T. Crump, Ross Thorne, et al.. (2019). DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation. Nature Communications. 10(1). 2803–2803. 93 indexed citations

2.

Stavropoulou, Vaia, Laurent Brault, Mathijs A. Sanders, et al.. (2016). MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome. Cancer Cell. 30(1). 43–58. 151 indexed citations

3.

Eyre, Toby A., I‐Jun Lau, Lucy Mackillop, & Graham P. Collins. (2015). Management and controversies of classical Hodgkin lymphoma in pregnancy. British Journal of Haematology. 169(5). 613–630. 17 indexed citations

4.

Gooding, Sarah, I‐Jun Lau, Pamela Roberts, et al.. (2015). Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs. PLoS ONE. 10(9). e0136207–e0136207. 10 indexed citations

5.

Lau, I‐Jun, Dean Smith, Norbert Blesing, et al.. (2014). Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide. Annals of Hematology. 94(4). 643–649. 14 indexed citations

6.

Voiculescu, Octavian, Lawrence Bodenstein, I‐Jun Lau, & Claudio D. Stern. (2014). Local cell interactions and self-amplifying individual cell ingression drive amniote gastrulation. eLife. 3. e01817–e01817. 65 indexed citations

7.

Gooding, Sarah, I‐Jun Lau, Pamela Roberts, et al.. (2013). Double Refractory Myeloma: Analysis Of Clinical Outcomes and Medical-Resource Utilisation In a Single Centre. Blood. 122(21). 1727–1727. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact